Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Dr Reddys Laboratories (RDY) Shares Outstanding (Diluted Average) (2016 - 2023)

Historic Shares Outstanding (Diluted Average) for Dr Reddys Laboratories (RDY) over the last 15 years, with Q2 2023 value amounting to $1.1 million.

  • Dr Reddys Laboratories' Shares Outstanding (Diluted Average) rose 2457.08% to $1.1 million in Q2 2023 from the same period last year, while for Jun 2023 it was $1.1 million, marking a year-over-year increase of 2457.08%. This contributed to the annual value of $1.0 million for FY2023, which is 951.2% up from last year.
  • Per Dr Reddys Laboratories' latest filing, its Shares Outstanding (Diluted Average) stood at $1.1 million for Q2 2023, which was up 2457.08% from $1.0 million recorded in Q1 2023.
  • In the past 5 years, Dr Reddys Laboratories' Shares Outstanding (Diluted Average) registered a high of $1.1 million during Q2 2023, and its lowest value of $15977.9 during Q3 2020.
  • In the last 5 years, Dr Reddys Laboratories' Shares Outstanding (Diluted Average) had a median value of $634322.7 in 2019 and averaged $654498.1.
  • As far as peak fluctuations go, Dr Reddys Laboratories' Shares Outstanding (Diluted Average) plummeted by 9614.42% in 2020, and later skyrocketed by 348820.32% in 2021.
  • Dr Reddys Laboratories' Shares Outstanding (Diluted Average) (Quarter) stood at $645692.7 in 2019, then decreased by 3.52% to $622952.7 in 2020, then tumbled by 88.73% to $70203.1 in 2021, then surged by 899.68% to $701807.4 in 2022, then skyrocketed by 53.97% to $1.1 million in 2023.
  • Its Shares Outstanding (Diluted Average) stands at $1.1 million for Q2 2023, versus $1.0 million for Q1 2023 and $701807.4 for Q4 2022.